Jakub Novosad, MD, PhD Institute of Clinical Immunology and Allergy, University Hospital in Hradec Králové, Czech Republic, physician, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic, assistant member of the Czech medical chamber, member of the Czech Society for Allergology and Clinical Immunology, member of the National Centre for Severe Asthma Research projects: 1) Multiple drug resistance of tumour cells (IGA MZ CR No. M/20-3/98) - coinvestigator, 2) The Centre for Proteomic study of intracellular parasitism (Ministry of Education, LN00A033 – Co, coinvestigator), 3) Serum periostin levels in patients who have bronchial asthma or IPF (Ministry of Health, principal investigator), 4) Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy (NCT05270278, March 8th, principal investigator) Awards: XXVIII EAACI Congress of the European Academy of Allergy and Clinical Immunology, Warszawa, Poland 2009, poster prize in section Inflammatory cells and Mediators I (Poster 662) XXIX EAACI Congress of the European Academy of Allergy and Clinical Immunology, London 2010, poster prize in section Innate and Adaptive Immunity (Poster 1744) 3rd International Severe Asthma Forum (ISAF), Manchester, 2016, poster prize